НовостиBenzingaJP Morgan Maintains Overweight on Seaport Therapeutics, Raises Price Target to $41 JP Morgan Maintains Overweight on Seaport Therapeutics, Raises Price Target to $41 Benzinga 2026.11.05 23:42 (GMT+0) Открыть на Benzinga Другие новости